Home / Themes / Cannabis '24: U.S. Cannabis Operators & MSOs
Last updated
Theme thesis · 2/5 sections · Tickers 0 with notes · 15 pending
Bull / Bear Details has the investment thesis and bull/bear points. Overview is monitoring guidance (hiring, forums, second-order trends, search keywords, Google Trends, datasets).
U.S. multi-state cannabis operators (MSOs) are poised for significant profitability improvements in 2026 due to the partial federal rescheduling of medical cann
U.S. multi-state cannabis operators (MSOs) are poised for significant profitability improvements in 2026 due to the partial federal rescheduling of medical cannabis, lifting the onerous 280E tax burden. Continued state-level market expansion and industry consolidation further support growth, despite ongoing federal illegality for adult-use and intense pricing pressures.
The partial rescheduling of medical cannabis to Schedule III in April 2026 has immediately removed the IRS 280E tax burden for qualifying medical operators, dramatically improving profitability and cash flow by allowing deduction of normal business expenses.
Continued state-level adult-use legalization, with 24 states and D.C. already legal, and the ongoing maturation of existing markets drive demand, premiumization, and product innovation. The expected ban on intoxicating hemp-derived THC products in November 2026 will also reduce competition for licensed MSOs.
The U.S. cannabis market is undergoing a consolidation phase, favoring well-capitalized MSOs with scale and efficiency. Federal rescheduling is also seen as a step towards institutionalization, potentially enabling listing of U.S. operators on major U.S. equity exchanges.
Despite medical cannabis rescheduling, adult-use cannabis remains federally illegal (Schedule I), creating ongoing challenges for interstate commerce, access to traditional banking, and capital markets. The SAFE Banking Act, though reintroduced in June 2026, faces historical hurdles to passage.
Mature state markets are experiencing significant price compression and intense competition, leading to declining retail prices and reduced profit margins for operators. This has resulted in the first-ever annual year-over-year revenue decline for the U.S. legal cannabis market in 2025.
The broader federal rescheduling process for all cannabis is still ongoing and subject to procedural steps and potential litigation, creating regulatory uncertainty. Furthermore, some states are seeing efforts to roll back or restrict existing cannabis legalization, adding regulatory headwinds at the state level.
General sentiment, news, and discussion around cannabis equities, including MSOs.
Investment-specific discussions, due diligence, and market analysis for cannabis companies.
Dedicated discussions and updates specifically on U.S. Multi-State Operators.
Discussions on MSO financial performance, regulatory changes, and stock movements.
Not in registry
Metric/field Total Monthly Adult-Use Cannabis Sales (USD) for key states (e.g., CA, FL, IL, MI, NY)
Cadence monthly
Why it matters Direct measure of market growth and consumer demand in core operating regions for MSOs.
Signal to watch Increasing sales indicate market expansion and stronger revenue potential.
Confidence: high
Not in registryaccess=api
Metric/field Personal Consumption Expenditures: Nondurable Goods (PCEND)
Cadence monthly
Why it matters Provides a broad indicator of consumer spending on goods, including cannabis products, reflecting overall economic health and discretionary income.
Signal to watch Rising PCE for nondurable goods suggests robust consumer spending.
Not in registryaccess=api
Metric/field Unemployment Rate by State (e.g., CAUR, FLUR, ILUR, MIUR, NYUR)
Cadence monthly
Why it matters Lower unemployment rates correlate with higher disposable income, which can drive increased consumer spending on cannabis.
Signal to watch Decreasing unemployment rates are a positive sign for consumer purchasing power.
Confidence: high
Not in registryaccess=api
Metric/field Federal Funds Effective Rate (DFF)
Cadence daily
Why it matters Influences the cost of capital for cannabis operators, impacting their ability to fund expansion and operations, especially given limited access to traditional banking.
Signal to watch Stable or decreasing rates generally reduce borrowing costs and support investment.
Confidence: high
Not in registry
Metric/field Total Monthly Cannabis Tax Revenue (USD) for key states (e.g., CA, CO, IL, MI, MA)
Cadence monthly
Why it matters Reflects the financial health and growth of the legal cannabis industry from a government perspective, which can influence regulatory stability and future policy decisions.
Signal to watch Increasing tax revenue indicates a growing and robust legal market.
Confidence: high
Not in registry
Metric/field Search Interest Index: 'dispensary near me' (US, 90-day rolling average)
Cadence daily
Why it matters Gauges real-time consumer curiosity and potential demand for cannabis retail, reflecting market engagement.
Signal to watch Sustained increase in search interest suggests growing consumer traffic and sales potential.
Not in registry
Metric/field Daily Post Volume and Net Sentiment Score for 'US MSO' and constituent tickers
Cadence daily
Why it matters Offers a pulse on retail investor and consumer perception, identifying emerging trends or sentiment shifts around the industry and specific operators.
Signal to watch Increasing positive sentiment and discussion volume can indicate growing interest and potential for positive market catalysts.
Confidence: medium
Not in registry
Metric/field Count of Active Federal and State Cannabis Reform Bills (e.g., legalization, rescheduling, tax reform)
Cadence event_driven
Why it matters Regulatory progress is a critical catalyst for the U.S. cannabis industry, directly impacting market access, operational costs, and growth opportunities for MSOs.
Signal to watch An increasing number of favorable legislative proposals or advancements signals a more supportive regulatory environment.
Confidence: high
Not in registry
Metric/field Total Number of Active Adult-Use Dispensary Licenses (by key state: CA, IL, MI, NY, MA, FL)
Cadence monthly/quarterly
Why it matters Direct indicator of market expansion and retail footprint growth, crucial for vertically integrated MSOs.
Signal to watch A rising number of licensed dispensaries suggests increasing market access and potential for higher sales volumes.
Confidence: high
Not in registry
Metric/field Frequency of News Articles Mentioning 'US Cannabis M&A' or 'Federal Cannabis Legalization'
Cadence daily
Why it matters Provides immediate insights into significant industry events, consolidation trends, and policy discussions that can materially impact MSO valuations and operational strategies.
Signal to watch Increased frequency of positive news related to M&A or federal reform indicates a dynamic and potentially improving market environment.
Not in registry
Metric/field Weekly Retail Sales Volume (USD) by Product Category (Flower, Edibles, Vapes) and Average Unit Price (by key state)
Cadence weekly
Why it matters Offers granular, real-time insights into consumer purchasing behavior, product trends, and pricing dynamics across core operating markets for MSOs.
Signal to watch Consistent growth in sales volume and stable or improving average unit prices indicate strong market demand and pricing power.
Confidence: high
Matchedplanet_high_resolution_satellite_imagery · access=file · map_only
Metric/field Estimated Cultivation Canopy Area (sq ft) and Activity Index for Major MSO Cultivation Facilities (by state)
Cadence irregular
Why it matters Provides an independent, objective measure of production capacity and operational scale for cultivation-heavy MSOs, offering insights into future supply.
Signal to watch Expansion in canopy area or increased activity suggests anticipated growth in harvest yields and revenue potential.
Confidence: medium
Not in registry
Metric/field Average Retail Price per Gram of Flower and Product Availability Index for Top 10 MSO Brands (by key state)
Cadence daily
Why it matters Tracks competitive pricing, product popularity, and inventory levels across the retail landscape, offering insights into supply-demand balance and brand performance.
Signal to watch Stable or increasing prices for popular products and consistent availability indicate strong brand demand and efficient supply chain management.
Confidence: high
Matchedbloomberg_second_measure_consumer_card_transactions · access=file · map_only
Metric/field Weekly Total Transaction Volume (USD) and Average Transaction Size at Cannabis Dispensaries (by key state/metro)
Cadence irregular
Why it matters Offers a direct, real-time view of consumer spending patterns and overall sales trends, providing an independent validation of market growth.
Signal to watch Sustained increases in transaction volume and average spend suggest robust consumer engagement and market expansion.
Confidence: high
Matchedlinkup_job_postings · access=file · map_only
Metric/field Total Number of Unique Job Postings for 'Cannabis Industry' (US) and by specific MSO (e.g., Curaleaf, Green Thumb Industries)
Cadence irregular
Why it matters Hiring activity is a leading indicator of business expansion, operational growth, and confidence in future demand within the industry and for individual operators.
Signal to watch A consistent increase in job postings suggests expansion plans and a positive outlook for the industry and specific companies.
Not in registryaccess=api
Market KXMJSCHEDULE-27
Why it matters Federal rescheduling of cannabis from Schedule I to a lower schedule (e.g., Schedule III) would remove the onerous 280E tax burden for medical cannabis operations, significantly improving profitability and cash flow for U.S. MSOs. This market directly gauges the likelihood of this critical regulatory change within the near term.
Series key pm_cannabis_reschedule_2027
Not in registryaccess=api
Market KXMJSCHEDULE-28
Why it matters Federal rescheduling of cannabis from Schedule I to a lower schedule (e.g., Schedule III) would remove the onerous 280E tax burden for medical cannabis operations, significantly improving profitability and cash flow for U.S. MSOs. This market provides a medium-term outlook on this pivotal regulatory reform.
Series key pm_cannabis_reschedule_2028
Not in registryaccess=api
Market KXMJSCHEDULE-29
Why it matters Federal rescheduling of cannabis from Schedule I to a lower drug schedule (e.g., Schedule III) would remove the onerous 280E tax burden for medical cannabis operations, significantly improving profitability and cash flow for U.S. MSOs. This market offers a longer-term perspective on federal cannabis reform, covering the remainder of the current presidential term.
Series key pm_cannabis_reschedule_2029
